Stocks / NASDAQ / BioTelemetry, Inc.

BioTelemetry, Inc.

Company Description

BioTelemetry, Inc. cardiac monitoring services, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services. It also develops proprietary integrated patient management platform that incorporates wireless data transmission network. The company operates through the following segments: Healthcare, Technology, and Research. The Healthcare segment focuses on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. The Technology segment engages in the development, manufacturing, testing, and marketing of medical devices to medical companies, clinics, and hospitals. The Research segment engages in the central core laboratory services that provides cardiac monitoring, scientific consulting, and data management services for drug and medical device trials. BioTelemetry company was founded on April 22, 2013 and is headquartered in Malvern, PA. [Source: MarketWatch]